1. Home
  2. FAX vs ARCT Comparison

FAX vs ARCT Comparison

Compare FAX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FAX
  • ARCT
  • Stock Information
  • Founded
  • FAX 1986
  • ARCT 2013
  • Country
  • FAX United States
  • ARCT United States
  • Employees
  • FAX N/A
  • ARCT N/A
  • Industry
  • FAX Investment Managers
  • ARCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FAX Finance
  • ARCT Health Care
  • Exchange
  • FAX Nasdaq
  • ARCT Nasdaq
  • Market Cap
  • FAX 654.7M
  • ARCT 298.3M
  • IPO Year
  • FAX N/A
  • ARCT N/A
  • Fundamental
  • Price
  • FAX $16.07
  • ARCT $13.78
  • Analyst Decision
  • FAX
  • ARCT Strong Buy
  • Analyst Count
  • FAX 0
  • ARCT 8
  • Target Price
  • FAX N/A
  • ARCT $52.83
  • AVG Volume (30 Days)
  • FAX 833.6K
  • ARCT 474.9K
  • Earning Date
  • FAX 01-01-0001
  • ARCT 08-04-2025
  • Dividend Yield
  • FAX 12.09%
  • ARCT N/A
  • EPS Growth
  • FAX N/A
  • ARCT N/A
  • EPS
  • FAX N/A
  • ARCT N/A
  • Revenue
  • FAX N/A
  • ARCT $143,680,000.00
  • Revenue This Year
  • FAX N/A
  • ARCT N/A
  • Revenue Next Year
  • FAX N/A
  • ARCT $34.79
  • P/E Ratio
  • FAX N/A
  • ARCT N/A
  • Revenue Growth
  • FAX N/A
  • ARCT 15.38
  • 52 Week Low
  • FAX $2.33
  • ARCT $8.04
  • 52 Week High
  • FAX $2.84
  • ARCT $25.88
  • Technical
  • Relative Strength Index (RSI)
  • FAX 57.17
  • ARCT 54.34
  • Support Level
  • FAX $15.93
  • ARCT $13.10
  • Resistance Level
  • FAX $16.45
  • ARCT $15.20
  • Average True Range (ATR)
  • FAX 0.26
  • ARCT 1.02
  • MACD
  • FAX -0.00
  • ARCT 0.07
  • Stochastic Oscillator
  • FAX 59.14
  • ARCT 55.21

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities and others.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

Share on Social Networks: